11 November 2023: Clinical Research
Comparative Analysis of Symptomatology in Hospitalized Children with RSV, COVID-19, and Influenza Infections
Weronika M. Balas 1BCDEF , Andrzej Śliwczyński 2CDE , Paweł Olszewski 3ACDE , Izabela Gołębiak 3CDE , Adam J. Sybilski 14ACDEF*DOI: 10.12659/MSM.941229
Med Sci Monit 2023; 29:e941229
Table 1 Risk of the occurrence of disease symptoms depending on the diagnosis (OR; [95%CI]) – in bold statistically significant values.
| COVID-19 | RSV | Influenza | |
|---|---|---|---|
| Occurrence of fever [≥38.6°C] | 1.57 [0.6–4.03] | 1 | |
| Presence of severe sleep-awakening cough | 1 | 0.92 [0.26–3.26] | |
| Presence of dyspnoea | 1.875 [0.57–6.15] | 1 | |
| Number of auscultatory changes | 1 | 1.28 [0.26–6.3] | |
| Wet cough vs dry cough | 0.18 [0.04–0.81] | 1 | 0.2 [0.06–0.7] |
| Presence of nasal discharge | 1 | 8.27 [0.94–72.52] | |
| Presence of nasal blockage | 1 | 0.92 [0.26–3.26] | |
| Duration of fever [≥4 days vs | 1 | 2.98 [0.81–10.88] | 0.84 [0.225–3.14] |
| Day of hospital admission [≥4 days vs | 1 | 1.2 [0.32–4.47] | |
| Decreases in saturation | 1 | 2.58 [0.86–7.76] | 0.711 [0.17–2.96] |
| Duration of hospitalisation [≥7 days vs | 1 | 3.31 [0.69–15.87] | 0.93 [0.12–7.08] |
| Presence of reddened. 0Inflamed throat | 1.1 [0.43–2.78] | 1 |